Not-so-walking pneumonia: challenges in managing mycoplasma complicated by autoimmune hemolytic anemia in a young female
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242968Keywords:
Atypical pneumonia, Mycoplasma pneumoniae, Autoimmune hemolytic anemia, Macrolide resistance, GlucocorticoidsAbstract
Mycoplasma pneumoniae (Eaton agent) is a leading cause of atypical community-acquired pneumonia and can present with serious complications like acute respiratory distress syndrome (ARDS), acute respiratory failure and a variety of extrapulmonary manifestations including significant hemolysis. In this case report, we describe a case of a 17-year-old female with Mycoplasma pneumonia accompanied by major complications including hemolysis and possible macrolide resistance and explore the clinical obstacles faced in its diagnosis and treatment. The patient presented to the emergency room with a 10-day history of high-grade fever, coryza and dry cough with worsening dyspnea and palpitations since one day. Along with routine hematological and radiological workup, molecular and serological investigations confirmed the diagnosis. The patient was managed by a multidisciplinary team and had a prolonged hospital stay. She was primarily managed with antibiotics followed by glucocorticoids. She was discharged with oral prednisolone in tapering doses and showed a favorable recovery on follow-up. This case highlights the importance of including Mycoplasma in the differential diagnosis for a young adult with pneumonia and extrapulmonary manifestations especially in cases of non-responsiveness to conventional beta lactam therapy. Macrolide resistant M. pneumoniae strains have increasingly become prevalent in Asia. The case also emphasizes the significance of early diagnosis and prompt intervention to reduce complications and aid quick recovery.
References
Widén J, Jönsson G, Karlsson U. Mycoplasma pneumonia with severe cold agglutinin hemolysis, thrombocytosis, leukemoid reaction and acute renal failure. IDCases. 2023;31:e01689.
Kumaravel Kanagavelu A, Nagumantry S, Sagi S, Oyibo S. A rare case of severe hemolytic anemia and pulmonary embolism secondary to Mycoplasma pneumoniae infection. J Med Cases. 2022;13.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728.
Narita M. Two unexpected phenomena in macrolide-resistant Mycoplasma pneumoniae infection in Japan and the unique biological characteristics of Mycoplasma pneumoniae. J Infect Chemother. 2011;17(5):735-6.
Salama A. Acquired immune hemolytic anemias. Ther Umsch. 2004;61(2):178-86.
Unni A, Hidayathulla PK, Kavitha KP, Paloth MN, Nair PR, Kumar P J, et al. A fulminant pneumonia due to Mycoplasma pneumoniae - Case report and literature review. IDCases. 2022;29:e01552.
Kumaravel Kanagavelu A, Nagumantry S, Sagi S, Oyibo S. A rare case of severe hemolytic anemia and pulmonary embolism secondary to Mycoplasma pneumoniae infection. J Med Cases. 2022;13.
Zhang T, Han C, Guo W, Ning J, Cai C, Xu Y. Case Report: Clinical Analysis of Fulminant Mycoplasma pneumoniae Pneumonia in Children. Front Pediatr. 2021;9:741663.
Talkington DF, Shott S, Fallon MT, Schwartz SB, Thacker WL. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol. 2004;11(5):862-7.
Calderaro A, Buttrini M, Farina B, Montecchini S, De Conto F, Chezzi C. Respiratory tract infections and laboratory diagnostic methods: A review with a focus on syndromic panel-based assays. Microorganisms. 2022;10(9):1856.
Thibodeau KP, Viera AJ. Atypical pathogens and challenges in community-acquired pneumonia. Am Fam Physician. 2004;69(7):1699-706.
Matsumoto M, Nagaoka K, Suzuki M, Konno S, Takahashi K, Takashina T, et al. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report. BMC Infect Dis. 2019;19(1):204.
Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiol Immunol. 2001;45(8):617-20.
